Abel Hall LLC’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$219K Buy
12,360
+237
+2% +$4K 0.04% 644
2026
Q2
$193K Buy
12,123
+69
+0.6% +$1.07K 0.03% 752
2026
Q1
$163K Hold
12,054
– – 0.03% 647
2025
Q4
$150K Buy
+12,054
New +$130K 0.04% 580

Other funds holding VTRS

Abel Hall LLC's VTRS Position: Q3 2026 in Review

Abel Hall LLC increased its Viatris (VTRS) stake by 2% in Q3 2026, buying an estimated $4K and bringing the position to 12,360 shares worth $219K. The position accounts for 0.04% of the portfolio, ranked #644.

Abel Hall LLC first reported a position in VTRS in Q4 2025 and has held it in 4 quarters since. 357 funds tracked by Wall St. Rank hold VTRS as of Q3 2026.

  • Abel Hall LLC held 12,360 shares of Viatris worth $219K as of Q3 2026.
  • Abel Hall LLC bought 237 Viatris shares in Q3 2026, an estimated $4K.
  • Viatris made up 0.04% of Abel Hall LLC's portfolio in Q3 2026, its #644 holding.
  • Abel Hall LLC first reported a position in Viatris in Q4 2025 and has held it in 4 quarters since.
  • 357 funds tracked by Wall St. Rank held Viatris as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.